http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-1417423-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_128214d0cf008fd46fb0b68419f6c5a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0af12fa10e20a1d7825fbfa159ca653a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-18
filingDate 1986-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86baed91e5778c217225b827bcdf735c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dc33fe54b993168dbf50af80a29323c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31113dcd066f0595e02469c53eb3c765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d35db9f5e81cf763aa092b659c791232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d25fb4ad92142ad4c456cc82ec99ac5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48fc374102ccf78ece0e9dab557f161e
publicationDate 1993-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-1417423-C
titleOfInvention 2-aminotazoline salts of n-aril- or n-(phenyl-2,3-dimethylpirazolone-5-yl-4)succinamine acid possessing analgetic activity
abstract SUBSTANCE: invention relates to substituted heterocyclic substances, in particular 2-aminothiazolinium salts of N-Ar or N - (- phenyl-2,3-dimethylpyrazolon-5-yl-4) cyccinamic acid, where Ag is Phenyl substituted in the p-position of SND, or in the m-position N0, which possesses analgesic 11; activity, “it can be used; used in medicine. The goal is the creation of new, more active substances of this class. Their synthesis is carried out from the corresponding L-substituted succinamic acid and 2-aminothiazoline in ethanol medium. Yield,%: mp. WITH; gross formula: a) 95.4; 129-13I; C, H, q N, 0.5; b) 95.3; 149-151; c) 98.2; 101-102; C, 5 Ng, L5045, g) 98; 159-161; C ,, H, bN405S; d) 94.4; .112-114; . An effective dose of ED is p mg / kg; toxicity, mg / kg: therapeutic index X-LD a / ZDuo: a) 50; 400 8; b) 37; 463; 12.5; c) 47; 585; 12.4; d) 44; 516; 11.7; d) 111; 906; 8.2. 3 tab. i (L C
priorityDate 1986-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408264951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421071222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3958041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426010419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396225

Total number of triples: 42.